Charles Xu
About Charles Xu
Charles Xu is the National Sales Director of Oncology at Bristol-Myers Squibb and the CEO of Hangzhou Medtap Information Technology Co., Ltd., based in Shanghai City, China.
Company
Charles Xu is the CEO of Hangzhou Medtap Information Technology Co., Ltd. He has been leading the company since its inception in January 2015. Medtap specializes in mobile health products with a focus on oncology, aiming to assist doctors in tracking patients and helping patients find appropriate doctors. The company is based in Hangzhou, Zhejiang, but Charles operates it from Shanghai City, China.
Title
Charles Xu holds the title of National Sales Director, Oncology at Bristol-Myers Squibb in Shanghai City, China. In this role, he is responsible for overseeing sales strategies and operations within the oncology sector, ensuring the company’s products reach the right markets and healthcare providers.
Education and Expertise
Charles Xu studied at China Europe International Business School (CEIBS), where he completed a Diploma in International Management Program (DIMP) from 2006 to 2007. His education has provided him with a strong foundation in business management, which has been invaluable in his various leadership roles within the pharmaceutical industry.
Background
Before his current roles, Charles Xu worked at Roche Pharmaceuticals as an Area Sales Manager from 2008 to 2012 in Shanghai. His experience at Roche allowed him to develop strong skills in sales management and oncology, which he has continued to build upon at Bristol-Myers Squibb and Medtap Information Technology Co., Ltd.
Extensive Pharmaceutical Industry Experience
Charles Xu has extensive experience in the pharmaceutical industry, holding significant roles at both Roche Pharmaceuticals and Bristol-Myers Squibb. His expertise lies primarily in oncology, and he has been instrumental in advancing sales and management within this specialized field. His work encompasses extensive engagement with healthcare providers and the implementation of effective sales strategies.